DRKS00025594
Completed
N/A
Reduction of care-related risks for older patients during and post acute hospital care - ReduRisk
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Functional decline, immobility, falls, delirium and rehospitalization
- Sponsor
- niversitätsklinikum Freiburg
- Enrollment
- 589
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •acute inpatients \= 70 years of age, increased risk for functional decline, immobility, falls, delirium, or rehospitalisation, informed consent
Exclusion Criteria
- •Patients receiving palliative care in the final phase.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Pro-active care for the older people at risk for functional decline: Screening for vulnerability and effectiveness of a subsequent guided care plan in primary careeerstelijns ouderengeneeskundeolder people with multiple problemsvulnerable elderlyNL-OMON33008eids Universitair Medisch Centrum10,000
Active, Not Recruiting
Phase 1
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.EUCTR2016-002272-27-BESaarland University388
Active, Not Recruiting
Phase 1
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.Patients with first relapse or progression of aggressive Non-Hodgkin’s Lymphoma who are not eligible neither for autologous nor allogeneic stem cell transplantationMedDRA version: 22.0Level: PTClassification code 10029547Term: Non-Hodgkin's lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2016-002272-27-ATSaarland University388
Active, Not Recruiting
Phase 1
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.EUCTR2016-002272-27-PTSaarland University388
Active, Not Recruiting
Phase 1
Improvement of Outcome in Elderly Patients or Patients not eligible forhigh-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma infirst Relapse or Progression by adding Nivolumab to Gemcitabine,Oxaliplatin plus Rituximab in case of B-cell lymphoma.EUCTR2016-002272-27-PLSaarland University388